Annual Report 2009 (US-GAAP)
Annual Report 2011 (US-GAAP)
Consolidated Financial Statements / Management Report 2010 (IFRS)
Consolidated Financial Statements / Management Report 2009 (IFRS)
Consolidated Financial Statements / Management Report 2008 (IFRS)
Financial Statement 2012 (HGB)
Annual Report 2012 (US-GAAP)
Consolidated Financial Statements / Management Report 2014 (IFRS)
Fresenius SE & Co KGaA will be included in the EURO STOXX 50 blue-chip index on September 21, 2015. The index update was announced by the Deutsche Börse subsidiary STOXX after the close of trading on Monday night. The EURO STOXX 50 index tracks the share price development of 50 large publicly traded companies, representing various economic sectors, from twelve Eurozone countries.
Fresenius joined Germany’s blue-chip DAX index in March 2009, and has continued to post strong growth since then. Group sales almost doubled from €12.3 billion in 2008 to €23.2 billion in 2014. Over the same period, adjusted Group net income increased from €450 million to €1.086 billion.
Fresenius, which has more than 220,000 employees worldwide, has ambitious growth targets for this year. Group sales for 2015 are expected to rise by 8% to 10% in constant currency, while adjusted Group net income is forecasted to increase by approximately 18% to 21% in constant currency.
This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.